The Week In Biopharma, June 20 – 24
Contract Research (CROs)
- Sanyou Biopharmaceuticals forged strategic partnership with Dragon Sail Pharmaceutical to upgrade integrated innovative antibody drug R&D (China)
Contract Development and Manufacturing (CDMO)
- Daewoong Pharmaceutical begins multinational phase 2 clinical trial for DWN12088, a new drug for idiopathic pulmonary fibrosis (South Korea)
- Qosina Strengthens Aseptic Capabilities (USA)
- Pierre Fabre and Lonza Enter Manufacturing Agreement (France/Switzerland)
- Fluent BioSciences launches industry’s most accessible, cost-effective and scalable technology (PIPseqTM) to accelerate adoption of single-cell RNA sequencing in any laboratory (USA)
- Eliaz Therapeutics Awarded $1.7 Million by NIH for XGAL3’s Apheresis Large Animal Safety Study (USA)
- Berry Oncology launches HIFI Pan-Cancer Screening, a multi-cancer early screening product for detecting six high-risk cancers at one time (China)
- MilliporeSigma Opens US$ 65 Million CDMO Facility to Address Demand for Critical Cancer Therapies (USA)
- CPC Scientific Announces New California Peptide API Manufacturing Facility (USA)
- Avantor, GeminiBio Partner on Custom Hydrated Solutions and Cell Culture Media (USA)
- BioNTech Breaks Ground on First mRNA Vax Mfg. Facility in (Africa)
- Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials (China)
- Bio-Techne to Acquire Namocell (USA)
- Medtronic reinforces spine surgery portfolio with FDA nod for ligament-augmenting implant (Ireland)
- BlueAllele® Corporation continues to advance therapeutic approaches using novel gene correction technologies and secures third patent from the USPTO (USA)
- MyOme Secures $23M in Series B Funding to Deliver Clinical Whole Genome Insights to Help Families Manage Risk for Inherited Diseases (USA)
- New Korus Technology Set to Transform Industry Standards in Elutriation and Cell Wash (USA)
- Ultima Genomics and Exact Sciences enter long-term supply agreement aimed at improving patient access to genomic testing by driving down sequencing costs (USA)
- Bioventus reworks $450M CartiHeal acquisition after scrapping original debt financing plan (USA)
- OrganaBio Launches Contract Cell Therapy Manufacturing Ops (USA)
Biopharma
- Stramsen Biotech Inc. Announced Eleven New Natural Plant-based Drug / Medicine Candidates During its Board Members’ Meeting (USA)
- AstraZeneca chips in another $68.7M to beef up Alexion’s manufacturing capabilities in (Ireland)
- European Commission Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent Patients (≥12 Years of Age) With Stage IIB or IIC Melanoma Following Complete Resection (USA)
- invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs (UK)
- RedHill Axes 1/3 of US Workforce in 18-Month Frugality Plan (USA)
- Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-2059, an Investigational Small Molecule-Based Radiopharmaceutical Targeting Solid Tumors Expressing NTSR1 (Canada)
- Novartis Tafinlar + Mekinist receives FDA approval for first tumor-agnostic indication for BRAF V600E solid tumors (USA)
- S. FDA Approves Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Infants and Children (USA)
- Antheia Receives $40 million in Venture Debt Financing (USA)
- Cullinan Oncology, Taiho to Develop & Commercialize CLN-081/TAS6417 in the (USA)
- Boehringer Ingelheim Canada Partners with Plug and Play Alberta to Advance Digital Health Innovation (Canada)
- Alladapt banks $119M to push immunotherapy through trials (USA)
- Novartis receives European Commission approval for Tabrecta® for the treatment of METex14 skipping advanced non-small cell lung cancer (USA)
- Precision BioSciences Announces In Vivo Gene Editing Collaboration with Novartis to Develop Potentially Curative Treatment for Disorders Including Sickle Cell Disease (USA)
- Galapagos to Acquire CellPoint and AboundBio (Belgium)
- Adaptive Biotechnologies Launches T Cell-based Test for Lyme Disease (USA)
- Phanes Therapeutics’ PT217 receives Orphan Drug Designation for small cell lung cancer from the FDA (USA)
- Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-Line Treatment for Esophageal Squamous Cell Carcinoma (China/USA)
- New Agreement Paves Way for Development of First African-owned COVID-19 Vaccine (South Africa)
- 3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform (Iceland)
- Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic gamma delta T-cell Therapy Candidate to Treat Patients with non-Hodgkin’s Lymphoma (USA)
- Carbon Biosciences exits stealth with $38M, unveils cystic fibrosis gene therapy candidate (USA)
- Abbvie’s SKYRIZI FDA-Approved as First IL-23 to Treat Crohn’s Disease (USA)
Artificial Intelligence
- Elucid clears $27M funding for heart disease diagnostic AI (USA)
- Caption Health launches AI-guided, at-home heart ultrasound service (USA)
